3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
7
Lung Neoplasms
3
Respiratory Tract Diseases
1
Osteosarcoma
1
Neoplasms
1
Neoplasm Metastasis
1
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
1
EGFR-mutant Non-small Cell Lung Cancer
1
Brain Neoplasms
1
Adenocarcinoma of Lung
1
Interventions
Carboplatin
48
Etoposide
47
durvalumab
29
atezolizumab
28
Cisplatin
21
Topotecan
19
PM 01183
17
pembrolizumab
15
Nivolumab
12
Specimen Handling
11
Paclitaxel
10
anlotinib
9
Radiotherapy
9
Drug Therapy
9
AMG 757
9
Temozolomide
8
Magnetic Resonance Spectroscopy
8
Radiosurgery
7
Platinum
7
Irinotecan
7
toripalimab
6
olaparib
6
Biopsy
6
Ipilimumab
5
Injections
5
Docetaxel
5
Bevacizumab
5
trilaciclib
4
tremelimumab
4
tislelizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
Gefitinib
×
1 year
×
Clear all
No trials found.